Cargando…
Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
Anticholinergics (ACs) are among the most prescribed drugs. Investigating the impaired cognitive domains due to individual ACs usage is associated with controversial findings. OBJECTIVE: The objective of this study was to investigate the effects of individual ACs on different aspects of cognitive fu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229087/ https://www.ncbi.nlm.nih.gov/pubmed/37261256 http://dx.doi.org/10.1590/1980-5764-DN-2022-0053 |
_version_ | 1785051163928821760 |
---|---|
author | Naseri, Amirreza Sadigh-Eteghad, Saeed Seyedi-Sahebari, Sepideh Hosseini, Mohammad-Salar Hajebrahimi, Sakineh Salehi-Pourmehr, Hanieh |
author_facet | Naseri, Amirreza Sadigh-Eteghad, Saeed Seyedi-Sahebari, Sepideh Hosseini, Mohammad-Salar Hajebrahimi, Sakineh Salehi-Pourmehr, Hanieh |
author_sort | Naseri, Amirreza |
collection | PubMed |
description | Anticholinergics (ACs) are among the most prescribed drugs. Investigating the impaired cognitive domains due to individual ACs usage is associated with controversial findings. OBJECTIVE: The objective of this study was to investigate the effects of individual ACs on different aspects of cognitive function based on clinical trial studies. METHODS: This systematic review was conducted following the PRISMA statement. A systematic search was performed in Embase, PubMed, Cochrane Library, Scopus, and Web of Science databases. Risk of bias (RoB) was assessed by the Joanna Briggs Institute checklists and the meta-analysis was performed using the CMA software. RESULTS: Out of 3,026 results of searching, 138 studies were included. A total of 38 studies that assess the cognitive impacts of scopolamine were included in the meta-analysis. Included studies reported cognitive effects of scopolamine, mecamylamine, atropine, biperiden, oxybutynin, trihexyphenidyl, benzhexol, and dicyclomine; however, glycopyrrolate, trospium, tolterodine, darifenacin, fesoterodine, tiotropium, and ipratropium were not associated with cognitive decline. Based on the meta-analyses, scopolamine was associated with reduced recognition (SDM -1.84; 95%CI -2.48 to -1.21; p<0.01), immediate recall (SDM -1.82; 95%CI -2.35 to -1.30; p<0.01), matching to sample (SDM -1.76; 95%CI -2.57 to -0.96; p<0.01), delayed recall (SDM -1.54; 95%CI -1.97 to -1.10; p<0.01), complex memory tasks (SDM -1.31; 95%CI -1.78 to -0.84; p<0.01), free recall (SDM -1.18; 95%CI -1.63 to -0.73; p<0.01), cognitive function (SDM -0.95; 95%CI -1.46 to -0.44; p<0.01), attention (SDM -0.85; 95%CI -1.38 to -0.33; p<0.01), and digit span (SDM -0.65; 95%CI -1.21 to -0.10; p=0.02). There was a high RoB in our included study, especially in terms of dealing with possible cofounders. CONCLUSION: The limitations of this study suggest a need for more well-designed studies with a longer duration of follow-up on this topic to reach more reliable evidence. |
format | Online Article Text |
id | pubmed-10229087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento |
record_format | MEDLINE/PubMed |
spelling | pubmed-102290872023-05-31 Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis Naseri, Amirreza Sadigh-Eteghad, Saeed Seyedi-Sahebari, Sepideh Hosseini, Mohammad-Salar Hajebrahimi, Sakineh Salehi-Pourmehr, Hanieh Dement Neuropsychol View & Review Anticholinergics (ACs) are among the most prescribed drugs. Investigating the impaired cognitive domains due to individual ACs usage is associated with controversial findings. OBJECTIVE: The objective of this study was to investigate the effects of individual ACs on different aspects of cognitive function based on clinical trial studies. METHODS: This systematic review was conducted following the PRISMA statement. A systematic search was performed in Embase, PubMed, Cochrane Library, Scopus, and Web of Science databases. Risk of bias (RoB) was assessed by the Joanna Briggs Institute checklists and the meta-analysis was performed using the CMA software. RESULTS: Out of 3,026 results of searching, 138 studies were included. A total of 38 studies that assess the cognitive impacts of scopolamine were included in the meta-analysis. Included studies reported cognitive effects of scopolamine, mecamylamine, atropine, biperiden, oxybutynin, trihexyphenidyl, benzhexol, and dicyclomine; however, glycopyrrolate, trospium, tolterodine, darifenacin, fesoterodine, tiotropium, and ipratropium were not associated with cognitive decline. Based on the meta-analyses, scopolamine was associated with reduced recognition (SDM -1.84; 95%CI -2.48 to -1.21; p<0.01), immediate recall (SDM -1.82; 95%CI -2.35 to -1.30; p<0.01), matching to sample (SDM -1.76; 95%CI -2.57 to -0.96; p<0.01), delayed recall (SDM -1.54; 95%CI -1.97 to -1.10; p<0.01), complex memory tasks (SDM -1.31; 95%CI -1.78 to -0.84; p<0.01), free recall (SDM -1.18; 95%CI -1.63 to -0.73; p<0.01), cognitive function (SDM -0.95; 95%CI -1.46 to -0.44; p<0.01), attention (SDM -0.85; 95%CI -1.38 to -0.33; p<0.01), and digit span (SDM -0.65; 95%CI -1.21 to -0.10; p=0.02). There was a high RoB in our included study, especially in terms of dealing with possible cofounders. CONCLUSION: The limitations of this study suggest a need for more well-designed studies with a longer duration of follow-up on this topic to reach more reliable evidence. Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2023-05-29 /pmc/articles/PMC10229087/ /pubmed/37261256 http://dx.doi.org/10.1590/1980-5764-DN-2022-0053 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License |
spellingShingle | View & Review Naseri, Amirreza Sadigh-Eteghad, Saeed Seyedi-Sahebari, Sepideh Hosseini, Mohammad-Salar Hajebrahimi, Sakineh Salehi-Pourmehr, Hanieh Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis |
title | Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis |
title_full | Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis |
title_fullStr | Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis |
title_full_unstemmed | Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis |
title_short | Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis |
title_sort | cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis |
topic | View & Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229087/ https://www.ncbi.nlm.nih.gov/pubmed/37261256 http://dx.doi.org/10.1590/1980-5764-DN-2022-0053 |
work_keys_str_mv | AT naseriamirreza cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis AT sadigheteghadsaeed cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis AT seyedisahebarisepideh cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis AT hosseinimohammadsalar cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis AT hajebrahimisakineh cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis AT salehipourmehrhanieh cognitiveeffectsofindividualanticholinergicdrugsasystematicreviewandmetaanalysis |